Cohen & Steers, Inc.
CNS News Today: Stay Updated with the Latest Cohen & Steers, Inc. News in Real Time
Find CNS news now at Meyka AI. Stay informed with the latest Cohen & Steers, Inc. stocks updates, including price news, market analysis, and expert insights.
^GSPC Today, April 11: Russia Oil Waiver Call, Ukraine Talk Denial
Russian oil sanctions waiver decision today and Kremlin denial of Ukraine peace talks could sway oil, inflation, and ^GSPC. What Singapore investors should watch now.
AAPL Stock Today: April 11 Hedge Funds Trim, Insider Sales Curb Rally
AAPL stock today: hedge funds trim stakes and April 2 insider selling cools momentum. Key levels, technicals, earnings date, and what Singapore investors should watch now.
YRI.TO Stock Leads Gold Sector: Yamana Gold Inc. Trading at CAD 7.89
Yamana Gold Inc. (YRI.TO) trades at CAD 7.89 on TSX. Meyka AI rates YRI.TO stock with B grade. Analyst consensus suggests HOLD on gold mining leader.
EHYD Stock Surges 42.8 Billion Percent on April 11, 2026: Hydrogen Energy Play
EHYD stock explodes 42.8B% on PNK exchange. Ehydrogen Solutions hydrogen tech gains momentum. Analysis and forecast inside.
CNS Analyst Rating Maintained at Outperform, April 2026
Evercore ISI maintains Outperform rating on CNS, lowers price target to $75 from $77 on April 10, 2026.
BIORQ stock plunges 99% on PNK: Biora Therapeutics faces severe decline
BIORQ stock crashes 99% to $0.000001 USD on PNK exchange. Biora Therapeutics faces critical valuation challenges in biotech sector.
0020.HK SenseTime Stock Faces Headwinds: AI Leader Down 0.98% in Pre-Market
SenseTime Group Inc. (0020.HK) trades at HK$2.01 with C- rating. AI stock shows weakness amid sector volatility on HKSE.
SNOW Stock Today: April 11 Agentic AI Fears Drive 10% Selloff
Snowflake stock today slumps as agentic AI fears spark a SaaS selloff. We cover price action, technicals, fundamentals, analyst views, and key catalysts for Australian investors.
LBRX Upgraded to Buy by Craig-Hallum on April 10, 2026
Craig-Hallum initiates LBRX analyst rating with Buy coverage on April 10, 2026, signaling bullish outlook for LB Pharmaceuticals.